Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study
Titel:
Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study
Auteur:
Nilsson, Sten Franzén, Lars Parker, Christopher Tyrrell, Christopher Blom, René Tennvall, Jan Lennernäs, Bo Petersson, Ulf Johannessen, Dag C Sokal, Michael Pigott, Katharine Yachnin, Jeffrey Garkavij, Michael Strang, Peter Harmenberg, Johan Bolstad, Bjørg Bruland, Øyvind S